Authorization of the First COVID-19 Vaccine: Details of the EUA

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity was planned to meet the educational needs of pharmacists and pharmacy technicians.

 This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview

Join us as we host John D. Grabenstein, RPh, PhD, FASHP, FAPhA, discuss what the near future may hold in terms of emergency use authorizations (EUAs) for one or more SARS-COV-2 vaccines to help prevent COVID-19. Dr. Grabenstein was a part of the very first EUA involving the anthrax vaccine in 2005, and has been closely monitoring the trials of SARS-CoV-2 vaccine candidates throughout 2020. We will discuss what a likely EUA would mean and what information is still needed for licensure, the makeup of the approaching vaccines, the distribution campaign, and standards for mass-immunization programs. The activity will help you make informed decisions for yourself, your patients, your teammates, and your organization as rollout of these novel vaccines begins.

1. Describe EUA status in regards to COVID-19 vaccine access.
2. Describe how clinicians should handle EUA differently than licensed vaccines.
3. Identify characteristics of leading vaccine candidates, including supply chain management considerations.
4. List resources for tracking additional COVID-19 vaccine candidates.

• John D. Grabenstein, R.Ph., Ph.D., FASHP, FAPhA, Editor, Immunization Action Coalition, President, Vaccine Dynamics
• Moderator: Eric Maroyka, Pharm.D., BCPS, Senior Director, Center on Pharmacy Practice Advancement, ASHP

In accordance with the ACPE's and ACCME's Standards for Commercial Support, anyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. In accordance with these Standards, all potential conflicts of interest have been resolved. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.

As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests. The existence or non-existence of relevant financial relationships will be disclosed to the activity audience. All identified conflicts of interest must be resolved prior to the activity.

• All planners, presenters, reviewers, and ASHP staff report no financial relationships relevant to this activity. 
  

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.